Patent · US Expired

Compounds

US6649619B1 · kind B1 · utility

15Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2003
Grant dateNov 18, 2003
Priority date
Expiry dateFeb 3, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pyrimidone compounds of formula (I): are inhibitors of the enzyme Lp-PLA2 and are of use in treating atheroscelerosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.